Literature DB >> 7526521

Benign prostatic hyperplasia: effects on quality of life and impact on treatment decisions.

W M Garraway1, R S Kirby.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7526521     DOI： 10.1016/s0090-4295(94)80194-0

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  7 in total

1.  Statin use and longitudinal changes in prostate volume; results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.

Authors:  Emma H Allott; Ilona Csizmadi; Lauren E Howard; Roberto L Muller; Daniel M Moreira; Gerald L Andriole; Claus G Roehrborn; Stephen J Freedland
Journal:  BJU Int       Date:  2019-09-27       Impact factor: 5.588

2.  Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.

Authors:  Jeannette M Schenk; Alan R Kristal; Marian L Neuhouser; Catherine M Tangen; Emily White; Daniel W Lin; Mario Kratz; Ian M Thompson
Journal:  Am J Epidemiol       Date:  2010-02-08       Impact factor: 4.897

3.  Quality of life of patients on the waiting list for benign prostatic hyperplasia surgery.

Authors:  A S Salinas-Sánchez; I Hernández-Millán; J G Lorenzo-Romero; M Segura-Martin; C Fernández-Olano; J A Virseda-Rodriguez
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

4.  Should modest elevations in prostate-specific antigen, International Prostate Symptom Score, or their rates of increase over time be used as surrogate measures of incident benign prostatic hyperplasia?

Authors:  Jeannette M Schenk; Rachel Hunter-Merrill; Yingye Zheng; Ruth Etzioni; Roman Gulati; Catherine Tangen; Ian M Thompson; Alan R Kristal
Journal:  Am J Epidemiol       Date:  2013-06-28       Impact factor: 4.897

5.  Quality of life in sexually active men with symptomatic benign prostatic hyperplasia : effects of treatment.

Authors:  Mel P Daly
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

6.  Evaluation of the effect of sildenafil and/or doxazosin on Benign prostatic hyperplasia-related lower urinary tract symptoms and erectile dysfunction.

Authors:  Ahmed Abolyosr; Gamal A Elsagheer; Mohammad S Abdel-Kader; Ahmed M Hassan; Abdel-Monem M Abou-Zeid
Journal:  Urol Ann       Date:  2013-10

7.  Quality of life after photo-selective vaporization and holmium-laser enucleation of the prostate: 5-year outcomes.

Authors:  Inyoung Sun; Sangjun Yoo; Juhyun Park; Sung Yong Cho; Hyeon Jeong; Hwancheol Son; Seung-June Oh; Jae-Seung Paick; Min Chul Cho
Journal:  Sci Rep       Date:  2019-06-04       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.